ESMA LIBRARY

The ESMA Library contains all ESMA documents. Please use the search and filter options to find specific documents.
25
DOCUMENTS

REFINE YOUR SEARCH

Sections

Type of document

Your filters
Vacancy X Summary of Conclusions X Statement X European Single Electronic Format X Corporate Governance X Trading X CCP Directorate X COVID-19 X
Reset all filters

Pages

Date Ref. Title Section Type Download Info Summary Related Documents Translated versions
25/11/2011 2011/397 Public statement on sovereign debt in IFRS financial statements Corporate Disclosure, Corporate Governance, IFRS Supervisory Convergence, Press Releases Statement PDF
189.46 KB
19/02/2013 2013/84 Feedback statement on the consultation regarding the role of the proxy advisory industry Corporate Disclosure, Corporate Governance Statement PDF
559.31 KB
12/11/2013 2013/1642 Information on shareholder cooperation and acting in concert under the Takeover Bids Directive Corporate Disclosure, Corporate Governance Statement PDF
321.63 KB		 The European Securities and Markets Authority (ESMA) has published a statement on practices governed by the Takeover Bid Directive (TBD), focused on shareholder cooperation issues relating to acting in concert and the appointment of board members. The statement contains a White List of activities that shareholders can cooperate on without the presumption of acting in concert. It also contains information on how shareholders may cooperate in order to secure board member appointments by setting out factors that national authorities may take into account when considering whether shareholders are acting in concert. The statement is in response to a request by the European Commission for clarity on these issues, following its 2012 report on the application of the TBD. It is based on information collected about the TBD’s application and common practices across the European Economic Area (EEA). The statement was prepared by the Takeover Bids Network, a permanent working group, under ESMA’s auspices, that promotes the exchange of information on practices and application of the TBD across EEA.
06/02/2020 ESMA70-156-2274 Public statement- Ensuring a common supervisory approach to secure compliance with the MiFIR pre-trade transparency requirements in commodity derivatives Trading Statement PDF
114.58 KB
27/02/2020 ESMA/2014/677-REV Information on shareholder cooperation and acting in concert under the Takeover Bids Directive Corporate Disclosure, Corporate Governance Statement PDF
368.97 KB

The European Securities and Markets Authority (ESMA) has published an update to its statement on practices governed by the Takeover Bid Directive (TBD), focused on shareholder cooperation issues relating to acting in concert and the appointment of board members. The update concerns a change to the Croatian creep-in threshold and secondary threshold in Appendix B. The statement contains a White List of activities that shareholders can cooperate on without the presumption of acting in concert. It also contains information on how shareholders may cooperate in order to secure board member appointments by setting out factors that national authorities may take into account when considering whether shareholders are acting in concert.The statement is in response to a request by the European Commission for clarity on these issues, following its 2012 report on the application of the TBD. It is based on information collected about the TBD’s application and common practices across the European Economic Area (EEA). The statement was prepared by the Takeover Bids Network, a permanent working group, under ESMA’s auspices, that promotes the exchange of information on practices and application of the TBD across EEA.
11/03/2020 ESMA71-99-1290 ESMA Statement on Markets and COVID-19 Board of Supervisors, COVID-19 Statement PDF
87.99 KB
20/03/2020 ESMA35-43-2348 ESMA Statement on COVID-19 telephone recording COVID-19, MiFID - Investor Protection Statement PDF
114.12 KB
20/03/2020 ESMA70-1556-2485 Public Statement Tick Sizes COVID-19, MiFID - Secondary Markets Statement PDF
79.25 KB
25/03/2020 ESMA32-63-951 Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 Corporate Disclosure, COVID-19 Statement PDF
135.91 KB
26/03/2020 ESMA80-191-995 COVID-19 Public Statement COVID-19, Securities Financing Transactions Statement PDF
113.93 KB
27/03/2020 ESMA31-67-742 Public statement on publication deadlines under the Transparency Directive COVID-19, Transparency Statement PDF
88.72 KB
31/03/2020 ESMA35-36-1919 Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 COVID-19, MiFID - Investor Protection Statement PDF
89.84 KB
09/04/2020 ESMA34-45-896 Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers COVID-19, Fund Management Statement PDF
113.03 KB
09/04/2020 ESMA80-187-546 Actions to mitigate the impact of COVID-19 on the EU financial markets regarding the timeliness of fulfilling external audit requirements for interest rate benchmarks under the Benchmarks Regulation Benchmarks, COVID-19 Statement PDF
89.31 KB
09/04/2020 ESMA70-155-9817 ESMA postpones the publication dates of the annual transparency calculations for non-equity instruments and for the quarterly systematic internaliser data for non-equity instruments other than bonds COVID-19, MiFID - Secondary Markets, MiFID II: Transparency Calculations and DVC Statement PDF
94.58 KB
04/05/2020 ESMA71-99-1324 Statement on bilateral margin RTS amendments in response to Covid-19 COVID-19, Joint Committee, Post Trading, Press Releases Statement PDF
101.16 KB
06/05/2020 ESMA35-43-2391 Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity COVID-19, MiFID - Investor Protection Statement PDF
118.75 KB
14/05/2020 ESMA50-158-2232 ESMA supports ESRB actions to address COVID-related systemic vulnerabilities COVID-19, Fund Management Statement PDF
81.33 KB
20/05/2020 ESMA32-63-972 Implications of the COVID-19 outbreak on the half-yearly financial reports Corporate Disclosure, COVID-19 Statement PDF
111.97 KB
11/06/2020 ESMA70-156-3070 Statement_Access ETDs COVID-19, MiFID - Secondary Markets, Post Trading Statement PDF
112.54 KB

Pages